Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00833404 · ClinicalTrials.gov registry record · Phase 1
Smoking Cessation and Sexual Health in Men
A Phase 1 study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
NCT00833404 is a Phase 1 study that has completed, run by University of Texas at Austin. The registered enrollment target is 80 participants.
The verdict
NCT00833404, a Phase 1 study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
Study Summary
This is a 12-week clinical trial investigating the effects of smoking cessation on sexual functioning in men. This study consists of 3 sessions and provides 8 weeks of free nicotine transdermal patches. It is hypothesized that men who quit smoking, compared to men who smoke as usual, will demonstrate improved sexual functioning, measured both physiologically (erectile functioning) and subjectively (self-reported sexual functioning).
Interventions
- DRUG Nicotine transdermal patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2008-12 |
| Est. Completion | 2010-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00833404
The ClinicalTrials.gov registry entry for NCT00833404 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nicotine transdermal patch is the first listed.
NCT00833404 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00833404 about?
NCT00833404 is a clinical study titled "Smoking Cessation and Sexual Health in Men". This is a 12-week clinical trial investigating the effects of smoking cessation on sexual functioning in men. This study consists of 3 sessions and provides 8 weeks of free nicotine transdermal patches. It is hypothesized that men who quit smoking, compared to men who smoke as usual, will demonstrat...
What is the current status of trial NCT00833404?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2008-12. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00833404?
The interventions under investigation include: Nicotine transdermal patch (DRUG).
Who is sponsoring clinical trial NCT00833404?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.